The company says its capacity is in the 100s of millions, and it is still investing the infrastructure to stay ahead of the ...

CDK4/6 inhibitors like abemaciclib and ribociclib improve invasive disease-free survival in breast cancer trials, but controversy surrounds study designs, bias, and cost-effectiveness, raising ...

After completing his education at IIT Bombay, he pursued a Master’s in Design and worked in New Delhi and Canada. Eventually, ...

Nebraska Gov. Jim Pillen will ask lawmakers to bar minors from joining social media apps without parental consent and ...

Legislation that has the potential to protect the agriculture chemical company Bayer from Iowa lawsuits related to its weed ...

Nexera Chain is the first compliance-ready Layer 1 blockchain purpose-built to meet the demands of institutional on-chain ...

The Iowa Senate passed such a bill last year to shield the company from legal claims it failed to warn people about negative ...

An international group of experts proposes two new categories of disease: preclinical and clinical obesity and the FDA ...

A consortium including scientists from the Tropical Institute at LMU University Hospital has demonstrated the effectiveness ...

At a time when the issue of gender-affirming care has become embroiled in legal and political battles, a team of ...

THE SOLVE-TAVI trial demonstrated that both valve type and anaesthesia strategy yielded comparable long-term outcomes in ...